from – The Washington Post – by Carolyn Y. Johnson
In a subterranean ballroom Wednesday morning, a panel representing three corners of the health-care system took on one of the most perplexing questions about drug prices: Why does the U.S. pay so much more for brand-name drugs than other wealthy nations?
The U.S. drug price premium has been shown again and again. It depends on the drug and the country, but a Reuters analysis found that the U.S. pays as much as seven times more than the United…
